+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interventional Neurology Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139887
The global market for Interventional Neurology Devices was estimated at US$3.6 Billion in 2023 and is projected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cerebral Embolization & Aneurysm Coiling Device segment, which is expected to reach US$2.0 Billion by 2030 with a CAGR of a 4.8%. The Cerebral Angioplasty & Stenting Systems segment is also set to grow at 3.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $974.3 Million in 2023, and China, forecasted to grow at an impressive 4.3% CAGR to reach $773.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Interventional Neurology Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Interventional Neurology Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Interventional Neurology Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, ACANDIS GmbH, B. Braun Melsungen AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 43 Featured):

  • Abbott Laboratories
  • ACANDIS GmbH
  • B. Braun Melsungen AG
  • Bayer AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • DePuy Synthes
  • evonos GmbH & Co. KG
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surtex Instruments
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Interventional Neurology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Incidence of Neurological Disorders Spurs Demand for Interventional Neurology Devices
  • Advancements in Imaging Technologies Propel Innovation in Neurovascular Interventions
  • Expansion of Minimally Invasive Surgical Techniques Drives Adoption of Neurology Devices
  • Shift Towards Catheter-Based Interventions Expands Market Opportunities
  • Role of Artificial Intelligence in Improving the Precision of Neurological Interventions
  • Increasing Use of Embolic Protection Devices Strengthens the Business Case for Adoption
  • Advancements in Thrombectomy Devices Propel Growth in Acute Stroke Management
  • Growing Importance of Early Diagnosis and Intervention in Neurovascular Conditions
  • Emerging Markets Present New Opportunities for Interventional Neurology Device Providers
  • Push for Cost-Effective Solutions in Stroke Treatment and Neurovascular Care
  • Role of Telemedicine and Remote Monitoring in Supporting Interventional Neurology
  • Increasing Focus on Patient-Centric Care and Customized Treatment Solutions
  • Growing Prevalence of Obesity Spurs Demand for Intragastric Balloons
  • Advancements in Minimally Invasive Weight Loss Solutions Propel Market Growth
  • Shift Towards Non-Surgical Bariatric Procedures Expands Market Opportunities
  • Rising Awareness of Obesity-Related Health Risks Drives Adoption of Intragastric Balloons
  • Increasing Focus on Lifestyle Modification and Weight Management Programs
  • Role of Multidisciplinary Approaches in Enhancing the Efficacy of Intragastric Balloons
  • Advancements in Balloon Design and Material Innovation Enhance Patient Safety and Comfort
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Interventional Neurology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Interventional Neurology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cerebral Embolization & Aneurysm Coiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Cerebral Embolization & Aneurysm Coiling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Cerebral Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Cerebral Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neurothrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Neurothrombectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Support by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Support by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Cerebral Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Cerebral Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cerebral Artery Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cerebral Artery Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
JAPAN
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
CHINA
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
EUROPE
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Interventional Neurology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Interventional Neurology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
FRANCE
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
GERMANY
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Interventional Neurology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
REST OF WORLD
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Interventional Neurology Devices by Device - Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Interventional Neurology Devices by Device - Percentage Breakdown of Value Sales for Cerebral Embolization & Aneurysm Coiling, Cerebral Angioplasty & Stenting Systems, Neurothrombectomy and Support for the Years 2014, 2024 & 2030
  • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of World Historic Review for Interventional Neurology Devices by Therapeutic Area - Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of World 16-Year Perspective for Interventional Neurology Devices by Therapeutic Area - Percentage Breakdown of Value Sales for Cerebral Aneurysm, Strokes, Cerebral Artery Stenosis and Other Therapeutic Areas for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Abbott Laboratories
  • ACANDIS GmbH
  • B. Braun Melsungen AG
  • Bayer AG
  • Biosensors International Group Ltd.
  • Boston Scientific Corporation
  • DePuy Synthes
  • evonos GmbH & Co. KG
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Surtex Instruments
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Table Information